Objective Focal epilepsies are the most common form observed and have not generally been considered to be genetic in origin. Recently, we identified mutations in DEPDC5 as a cause of familial focal epilepsy. In this study, we investigated whether mutations in the mammalian target of rapamycin (mTOR) regulators, NPRL2 and NPRL3, also contribute to cases of focal epilepsy. Methods We used targeted capture and next-generation sequencing to analyze 404 unrelated probands with focal epilepsy. We performed exome sequencing on two families with multiple members affected with focal epilepsy and linkage analysis on one of these. Results In our cohort of 404 unrelated focal epilepsy patients, we identified five mutations in NPRL2 and five in NPRL3. Exome sequencing analysis of two families with focal epilepsy identified NPRL2 and NPRL3 as the top candidate-causative genes. Some patients had focal epilepsy associated with brain malformations. We also identified 18 new mutations in DEPDC5. Interpretation We have identified NPRL2 and NPRL3 as two new focal epilepsy genes that also play a role in the mTOR-signaling pathway. Our findings show that mutations in GATOR1 complex genes are the most significant cause of familial focal epilepsy identified to date, including cases with brain malformations. It is possible that deregulation of cellular growth control plays a more important role in epilepsy than is currently recognized.

Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy / Ricos, Michael G.; Hodgson, Bree L.; Pippucci, Tommaso; Saidin, Akzam; Ong, Yeh Sze; Heron, Sarah E.; Licchetta, Laura; Bisulli, Francesca; Bayly, Marta A.; Hughes, James; Baldassari, Sara; Palombo, Flavia; Santucci, Margherita; Meletti, Stefano; Berkovic, Samuel F.; Rubboli, Guido; Thomas, Paul Q.; Scheffer, Ingrid E.; Tinuper, Paolo; Geoghegan, Joel; Schreiber, Andreas W.; Dibbens, Leanne M.. - In: ANNALS OF NEUROLOGY. - ISSN 0364-5134. - STAMPA. - 79:(2016), pp. 120-131. [10.1002/ana.24547]

Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy

MELETTI, Stefano;
2016

Abstract

Objective Focal epilepsies are the most common form observed and have not generally been considered to be genetic in origin. Recently, we identified mutations in DEPDC5 as a cause of familial focal epilepsy. In this study, we investigated whether mutations in the mammalian target of rapamycin (mTOR) regulators, NPRL2 and NPRL3, also contribute to cases of focal epilepsy. Methods We used targeted capture and next-generation sequencing to analyze 404 unrelated probands with focal epilepsy. We performed exome sequencing on two families with multiple members affected with focal epilepsy and linkage analysis on one of these. Results In our cohort of 404 unrelated focal epilepsy patients, we identified five mutations in NPRL2 and five in NPRL3. Exome sequencing analysis of two families with focal epilepsy identified NPRL2 and NPRL3 as the top candidate-causative genes. Some patients had focal epilepsy associated with brain malformations. We also identified 18 new mutations in DEPDC5. Interpretation We have identified NPRL2 and NPRL3 as two new focal epilepsy genes that also play a role in the mTOR-signaling pathway. Our findings show that mutations in GATOR1 complex genes are the most significant cause of familial focal epilepsy identified to date, including cases with brain malformations. It is possible that deregulation of cellular growth control plays a more important role in epilepsy than is currently recognized.
12-dic-2015
79
120
131
Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy / Ricos, Michael G.; Hodgson, Bree L.; Pippucci, Tommaso; Saidin, Akzam; Ong, Yeh Sze; Heron, Sarah E.; Licchetta, Laura; Bisulli, Francesca; Bayly, Marta A.; Hughes, James; Baldassari, Sara; Palombo, Flavia; Santucci, Margherita; Meletti, Stefano; Berkovic, Samuel F.; Rubboli, Guido; Thomas, Paul Q.; Scheffer, Ingrid E.; Tinuper, Paolo; Geoghegan, Joel; Schreiber, Andreas W.; Dibbens, Leanne M.. - In: ANNALS OF NEUROLOGY. - ISSN 0364-5134. - STAMPA. - 79:(2016), pp. 120-131. [10.1002/ana.24547]
Ricos, Michael G.; Hodgson, Bree L.; Pippucci, Tommaso; Saidin, Akzam; Ong, Yeh Sze; Heron, Sarah E.; Licchetta, Laura; Bisulli, Francesca; Bayly, Marta A.; Hughes, James; Baldassari, Sara; Palombo, Flavia; Santucci, Margherita; Meletti, Stefano; Berkovic, Samuel F.; Rubboli, Guido; Thomas, Paul Q.; Scheffer, Ingrid E.; Tinuper, Paolo; Geoghegan, Joel; Schreiber, Andreas W.; Dibbens, Leanne M.
File in questo prodotto:
File Dimensione Formato  
2016_Ricos_et_al-Annals_of_Neurology.pdf

non disponibili

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 603.17 kB
Formato Adobe PDF
603.17 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1102748
Citazioni
  • ???jsp.display-item.citation.pmc??? 54
  • Scopus 127
  • ???jsp.display-item.citation.isi??? 118
social impact